Here's what Big Pharma could buy in 2025, from obesity drugs to precision cancer treatments, according to a top M&A ...
A top M&A banker said Big Pharma will be on the hunt for more acquisitions in 2025. Major drugs including Keytruda and Eliquis will see patent exclusivity expire in coming years. Pharma companies look at areas such as obesity to supplement growth, …